ON THE ROAD TO A CURE

"... because every child deserves to be healthy."



WHAT IS GSD1?

Glycogen Storage Disease Type 1 (GSD1) is a rare, genetic metabolic disorder that occurs when a specific enzyme is either missing or not functioning properly.  This enzyme is responsible for maintaining the body's blood glucose (sugar) level.  Glucose fuels every cell in our body, including brain activity.  People affected with GSD1 cannot convert stored glycogen into glucose, and therefore need a constant external source of glucose in order to survive.  Hypoglycemia in patients with GSD1 can be life threatening.  GSD1 is the most common form Glycogen Storage Disease, affecting 1 in every 100,000 births.   READ MORE

The Children's Fund for Glycogen Storage Disease Research is a public not-for-profit 501(c)(3) foundation that aims to make a difference in the lives of children and their families affected by GSD1. 

View More

As little as 40 years ago, a child born with GSD1 had very little chance of survival beyond one or two years. Today, thanks to increased awareness, medical advances and generous supporters, children are thriving and a cure is on the horizon.

VIEW MORE

Did you know…

The Children’s Fund for GSD Research is the only public charity in the world dedicated to funding research for Glycogen Storage Disease Type 1.
Over $8 Million Funded
Since 2002, The Children's Fund for GSD Research has granted over $8 million, which has led to groundbreaking therapies and an improved quality of life for people with GSD1. To date, we have funded almost 60 studies, helping scientists pursue new ideas and investigate probable approaches to improve treatment and uncover a cure. 
100% Volunteer Based
Our ultimate goal is a to live in a world where GSD does not exist. The Children's Fund for GSD Research is leading the charge towards this reality. All fundraising and administration are done on a volunteer basis so that nearly 100% of all contributions can be used to support our mission. Join our cause!

News and Events

  • Super Bowl
    Raffle

    Its time for our annual Super Bowl Raffle for GSD! Purchase a raffle ticket and you could be going to California for Super Bowl LX on February 8th!
  • Beam
    Clinical Trials

    Beam Therapeutics is continuing to enroll adult participants in a Phase 1 / 2 trial evaluating BEAM-301 for the potential treatment of GSD1a. There are three clincial study sites open across the United States. Please contact clinicalinfo@beamtx.com for more information. 

     

     

  • Ultragenyx submits
    BLA to FDA!

    Last week, Ultragenyx announced the initiation of a rolling submission of a BLA to the U.S. FDA seeking approval for their investigational gene therapy for patients with GSD1a. They plan to complete the BLA submission in the fourth quarter of 2025. Click the graphic to learn about the process and the timeline. 

     

     

  • GSD1a Meeting with the FDA

    On October 9, 2025 The Children's Fund for GSD Research hosted an Externally Led Patient Focused Drug Development (EL-PFDD) Meeting where patients and caregivers shared their stories to help shape the future of treatment for GSD1a.  Please visit the EL-PFDD information page to learn more and watch the Live Stream recording.
  • Gene Editing
    Clinical Trials

    Human clinical trials have started and the first GSD1a patient was dosed using novel gene editing technology. We are so grateful for the GSD teams at The University of Connecticut, UConn Health and Beam Therapeutics for getting us here.

  • Research at UConn Continues

    We are thrilled to continue our support of Dr. Youngmok Lee and the GSD Lab at UConn Health. Thank you Dr. Lee for your dedication and commitment to find a cure for Glycogen Storage Disease.
CONFIG TEMPLATE

This template controls the elements:

FOOTER: Footer Title, Footer Descriptions
CUSTOM MENU: Images and columns into header main menu submenu items

* This message is only visible in administrative mode

" ... because every child deserves to be healthy."

Stay Up To Date:

We may use cookies to give you the best experience on our website.
In accordance with our Privacy Policy, you hereby agree to our use of cookies on this device.